<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Leukoencephalopathy | Jeroen Van Schependom</title><link>https://jeroenvanschependom.be/tag/leukoencephalopathy/</link><atom:link href="https://jeroenvanschependom.be/tag/leukoencephalopathy/index.xml" rel="self" type="application/rss+xml"/><description>Leukoencephalopathy</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Tue, 01 Mar 2016 00:00:00 +0000</lastBuildDate><image><url>https://jeroenvanschependom.be/media/icon_hu898bad6a947579ff95e6bfac4d9757a2_264109_512x512_fill_lanczos_center_3.png</url><title>Leukoencephalopathy</title><link>https://jeroenvanschependom.be/tag/leukoencephalopathy/</link></image><item><title>Assessing PML risk under immunotherapy: if all you have is a hammer, everything looks like a nail.</title><link>https://jeroenvanschependom.be/publication/van-schependom-assessing-2016/</link><pubDate>Tue, 01 Mar 2016 00:00:00 +0000</pubDate><guid>https://jeroenvanschependom.be/publication/van-schependom-assessing-2016/</guid><description/></item></channel></rss>